We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KEQU:NASDAQKewaunee Scientific Corporation analysis

Data as of Sep 26, 2026 - not real-time

Latest price
$34.02
Risk: medium
7/10Medium risk

Summary

Kewaunee Scientific Corporation is priced at $34.02 and its moving averages line up in bearish order, the shorter trailing the longer. Across the trailing 30 sessions it lost 6.9%. Momentum indicators put RSI at 38.6 (approaching oversold) with MACD reading bearish. Price has been bracketed by support at $32.00 and resistance at $37.84.
Multiples put this in fair territory at a P/E of 12.2. Revenue is contracting at 6.7% on a 3.0% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 27.0%, a beta of 0.68 and a maximum drawdown of 26.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top market events

  • Price-action only: Kewaunee Scientific Corporation KEQU movements set the tone for institutional models.
  • Kewaunee Scientific Corporation NASDAQ: KEQU today announced that the Company plans to release its first quarter fiscal...
  • Kewaunee Scientific Corporation NASDAQ: KEQU today announced the appointment of Jorge Santos as VP – International...

Market outlook

Short term

< 1 year

Cautious

Model confidence7/107 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 37.41
  • MACD momentum is negative

Medium term

1–3 years

Cautious

Model confidence5/105 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 37.41
  • MACD momentum is negative

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Revenue contracting at -6.7%
  • P/E ratio of 12.2
  • Price-to-book of 1.31

Key metrics

Financial health

Revenue Growth-6.70%
Profit Margin2.97%
P/E Ratio12.2
ROE12.53%
ROA5.10%
Debt/Equity71.84
P/B Ratio1.3
Op. Cash Flow$14.8M
Free Cash Flow$9.2M

Technical analysis

TrendBearish
RSI38.6
Support$32.00
Resistance$37.84
MA 20$35.52
MA 50$36.21
MA 200$37.41
MACDBearish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$21.96
GradeFair
TypeValue

Risk assessment

Beta0.68
Volatility26.97%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.